SC 13D Filing

Company

FENNEC PHARMACEUTICALS INC.

Filed

November 26, 2013

Accession Number

0000919574-13-006805

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →